Effects of soybean ethanol extract on the cell survival and oxidative stress in osteoblastic cells

Phytotherapy Research

Volumn 17, Issue 6, 2003, Pages 627-632

  Choi, Eun Mi ^a   Koo, Sung Ja ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Glycine max; Nitric oxide; Osteoblast; Soybean; TNF

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; NITRIC OXIDE; NITRITE; PLANT EXTRACT; SCAVENGER; SOYBEAN ETHANOL EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL POLARITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OXIDATIVE STRESS; RHEUMATOID ARTHRITIS; SOYBEAN;

ALKALINE PHOSPHATASE; APOPTOSIS; ARTHRITIS, RHEUMATOID; FREE RADICAL SCAVENGERS; HUMANS; NITRIC OXIDE; OSTEOBLASTS; OXIDATIVE STRESS; PHYTOTHERAPY; PICRATES; PLANT EXTRACTS; SOYBEANS; TUMOR NECROSIS FACTOR-ALPHA;

GLYCINE MAX;

EID: 0037787792     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1213     Document Type: Article

References (30)

1. Arjmandi BH, Alekel L, Hollis BW et al. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167.
2. Bonfoco E, Leist M, Zhivitivsky B et al. 1996. cytoskeletal breakdown and apoptosis elicited by NO donors in cerebellar granule cells require NMDA receptor activation. J Neurochem 67: 2484-2493.
3. Bosca L, Hortelano S. 1999. Mechanisms of NO-dependent apoptosis: involvement of mitochondrial mediators. Cell Signal 11: 239-244.
4. Centrella M, Canalis E. 1985. Transforming and non-transforming growth factors are present in medium conditioned by fetal rat calvariae. Proc Natl Acad Sci USA 82: 7325-7339.
5. Choi EM, Suh KS, Kim YS et al. 2001. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry 56(7): 733-739.
6. Choi JS, Kwon TW, Kim JS. 1996. Isoflavone contents in some varieties of soybean. Foods Biotechnol 5(2): 167-169.
7. Damoulis PD, Hauschka PV 1997. Nitric oxide acts in conjugation with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 12: 412-422.
8. Erickson SL, de Sauvage FJ, Kikly K et al. 1994. Decreased sensitivity to TNF but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563.
9. Evans DM, Ralston SH. 1996. Nitric oxide and bone. J Bone Miner Res 11: 300-305.
10. Guyton KZ, Gorospe M, Holbrook NJ. 1997. Oxidative stress, gene expression and the aging process. In Oxidative Stress and the Molecular Biology of Antioxidant Defences, Scandalios JG (ed.) New York: Cold Spring Harbor Laboratory Press; 247-272.
11. Halliwell B, Gutteridge JMC. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85.
12. 2. Free Radic Res Commun 18: 195-199.
13. Hukkanen M, Hughes FJ, Lee D et al. 1995. Cytokine stimulated expression of inducible nitric oxide synthase by mouse, rat and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136: 5445-5453.
14. Ioannidis I, DeGroot H. 1993. Cytotoxicity of NO in FU5 hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem J 296: 341-345.
15. Ishida H, Uesugi T, Hirai K et al. 1998. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21: 62-66.
16. Jacobson MD. 1996. Reactive oxygen species and programmed cell death. Trends Biochem Sci 21: 83-86.
17. Kehre JP. 1993. Free radicals as mediators of tissue injury and disease. Cri Rev Toxicol 23: 21-48.
18. Kim JY, Maeng YS, Lee KY. 1995. Antioxidative effects of soybean extracts by using various solvents. Korean J Food Sci Technol 27(5): 635-639.
19. Kimble RB, Matayoshi AB, Vannice JL et al. 1995. Simultaneous block of IL-1 and TNF is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 3054-3061.
20. Lowik CWGM, Nibbering PH, Van der Ruit M, Papapoulos SE. 1994. Inducible production of nitric oxide in osteoblast like cells and in fetal bone explants is associated with supression of osteoclastic bone resorption. J Clin Invest 93: 1465-1472.
21. Mayer B, Hemmens B. 1997. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22: 477-481.
22. MeBmer UK, Brune B. 1996. NO in apoptotic versus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD content, and p53 accumulation. Arch Biochem Biophys 327: 1-10.
23. Pacifini R, Brown C, Puscheck E et al. 1991. Effect of surgical menopause and estrogen replacement in cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88: 5134-5138.
24. Pansini F, Bonaccorsi G, Albertaza P et al. 1997. Soy phytoestrogens and bone. North American Menopause Society Meetings, Abstract 97.061: 44.
25. Raize LG, Martin TJ. 1983. Prostaglandins in bone and mineral metabolism. In Bone & Mineral Research, vol 2, Peck WA (ed.) Elsevier/North Holland: Amsterdam; 286-310.
26. Ralston SH, Todd D, Helfrich M et al. 1994. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336.
27. Rothe J, Lesslauer W, Lotscher H et al. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802.
28. Schmidt HHHW, Walter U. 1994. NO at work. Cell 78: 919-925.
29. Shimada K, Fujikawa K, Yahara K, Nakamura T. 1992. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J Agricultural Food Chem 45: 1152-1155.
30. Vandenabeele P, Declercq W, Vanhaesebroeck B et al. 1995. Both TNF receptors are required for TNF-mediated induction of qpoptosis in PC60 cells. J Immunol 154: 2904-2913.